Medtronic Begins Pediatric Clinical Trial of Spinal Tether for Treatment of Scoliosis

By Robb M. Stewart

Medtronic PLC said Wednesday it has begun a pediatric clinical trial of its spinal chain for the treatment of scoliosis.

The medical technology company said it has enrolled its first patient and completed the first surgical procedure in its Braive IDE trial, which will evaluate the safety and effectiveness of the growth modulation system for treating progressive idiopathic scoliosis in adolescents.

The first patient was recruited by the Newcastle Upon Tyne Hospitals NHS Foundation Trust in England. The device is Medtronic’s latest in the pediatric spine category, and the launch of the study reaffirms the company’s commitment to continued innovation for pediatric patients, it said.

In morning trading, Medtronics shares rose 1% to $129.09, a 10% gain since late last year.

Write to Robb M. Stewart at robb.stewart@wsj.com

Comments are closed.